Pseudolaric acid B induces mitotic arrest and apoptosis in both imatinib-sensitive and -resistant chronic myeloid leukaemia cells
作者: Liling JiangChuangyu WenQingyan HeYuening SunJinxiang WangXiaoying LanSagar RohondiaQ. Ping DouXianping ShiJinbao Liu
作者单位: 1Guangzhou Municiple and Guangdong Provincial Key Lab of Protein Modification and Degradation Lab, State Key Lab of Respiratory Disease, School of Basic Medical Sciences, Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
2Department of Obstetrics and Gynaecology, Dongguan Affiliated Hospital, Southern Medical University, Dongguan, Guangdong, China
3The Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Departments of Oncology, Pharmacology and Pathology, School of Medicine, Wayne State University, Detroit, MI, USA
刊名: European Journal of Pharmacology, 2020, Vol.876
来源数据库: Elsevier Journal
DOI: 10.1016/j.ejphar.2020.173064
关键词: Chronic myeloid leukaemia cellsPABBCR-ABLApoptosisCell cycleDrug resistance
英文摘要: Abstract(#br)The selective BCR-ABL tyrosine kinase inhibitor imatinib is one of the first-line therapies in the management of chronic myeloid leukaemia (CML). However, acquired resistance to this inhibitor, which is especially conferred by the T315I point mutation in BCR-ABL, impedes the efficacy of imatinib therapy. Therefore, the discovery and development of novel agents to overcome imatinib resistance is urgently needed. Pseudolaric acid B (PAB), a small molecule isolated from the traditional Chinese medicine Cortex pseudolaricis , has been reported to be a potential candidate for immune disorders and cancer treatment. However, its effects on CML and the involved molecular mechanism have not been reported. In the current study, by performing both in vitro and in vivo experiments in CML...
全文获取路径: Elsevier  (合作)
影响因子:2.592 (2012)

  • leukaemia 白血病
  • mitotic 有丝分裂的
  • myeloid 骨髓的
  • resistant 耐久的
  • arrest 制动器
  • cells 麻风细胞
  • sensitive 灵敏的
  • chronic 延续很长的
  • apoptosis 细胞死